Trials / Completed
CompletedNCT02066324
Urine Sample Collection From FOP Patients
Urine Sample Collection From Patients With Fibrodysplasia Ossificans Progressiva (FOP) for Biomarker Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 5 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect urine samples from patients with fibrodysplasia ossificans progressiva (FOP) for the assessment of biomarkers related to disease, disease progression and for prediction of flare-ups of the disease. Disease related biomarkers in these patients are currently unknown. This study aims to support the development of novel therapy/ies for this disease.
Conditions
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-02-19
- Last updated
- 2015-03-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02066324. Inclusion in this directory is not an endorsement.